F. Landon Clark, MD
Dermatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Clark’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A98593 · Current
Licensed to practise in California · since 2007 · expires 2028-03-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$218,231
Medicare paid this office $218,231 for 649 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 311 | $54,647 | $108 |
| Short return visit (20+ min) | 293 | $31,058 | $74 |
| Destruction of skin growth, 1-14 growths | 236 | $30,903 | $110 |
| Destruction of precancer skin growth, 1 growth | 313 | $20,219 | $46 |
| Biopsy of related skin growth, first growth | 175 | $17,845 | $87 |
See all 15 services
| Return visit (30+ min) | 311 | $54,647 | $108 |
| Short return visit (20+ min) | 293 | $31,058 | $74 |
| Destruction of skin growth, 1-14 growths | 236 | $30,903 | $110 |
| Destruction of precancer skin growth, 1 growth | 313 | $20,219 | $46 |
| Biopsy of related skin growth, first growth | 175 | $17,845 | $87 |
| New patient visit (45+ min) | 100 | $13,577 | $136 |
| New patient visit (30+ min) | 96 | $8,447 | $88 |
| Application of ultraviolet light to skin | 11 | $7,396 | $27 |
| Destruction of precancer skin growth, 2-14 growths | 227 | $7,277 | $7 |
| Punch biopsy, first skin growth | 38 | $4,887 | $122 |
| Destruction of precancer skin growth, 15 or more growths | 21 | $4,114 | $165 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 11 | $3,223 | $293 |
| Biopsy of related skin growth, each additional growth | 25 | $1,602 | $52 |
| Short return visit | 16 | $835 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $34 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 1113 | More than 94% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 337 | More than 92% of doctors who do this |
Who their Medicare patients are
649 Original Medicare patients in 2024. Average age 74 · Women 48% · Also on Medicaid 5% · Health risk score 0.89. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 57% · Diabetes 18% · Coronary heart disease 17% · Cancer 16% · Chronic kidney disease 13% · Atrial fibrillation 13% · Depression 10% · Heart failure 7% · COPD 7% · Dementia 3% · Stroke 3%.
The office billed $800,611, Medicare allowed $304,574 and paid $218,231; for 3,646 services of 44 kinds; $342 of it was for drugs given in the office and $217,890 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 649 | 3,646 | 74 | 0.89 | $800,611 | $218,231 |
| 2023 | 530 | 3,299 | 74 | 0.95 | $712,224 | $198,844 |
| 2022 | 597 | 3,243 | 76 | 0.95 | $652,163 | $181,768 |
| 2021 | 723 | 4,623 | 75 | 0.89 | $955,111 | $280,818 |
| 2020 | 705 | 4,449 | 75 | 0.95 | $838,973 | $229,622 |
| 2019 | 721 | 4,350 | 75 | 0.94 | $860,473 | $225,231 |
| 2018 | 617 | 3,335 | 75 | 0.92 | $565,910 | $146,687 |
| 2017 | 698 | 4,494 | 75 | 0.98 | $778,669 | $220,465 |
| 2016 | 591 | 4,057 | 75 | 0.95 | $719,415 | $194,150 |
| 2015 | 574 | 3,621 | 75 | 1.01 | $688,572 | $198,393 |
| 2014 | 492 | 3,347 | 74 | 0.99 | $609,428 | $182,868 |
| 2013 | 408 | 2,840 | 75 | 1.02 | $504,803 | $146,335 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 247 | $43,497 | $110 |
| Short return visit (20+ min) | 250 | $26,694 | $70 |
| Destruction of skin growth, 1-14 growths | 182 | $25,070 | $107 |
| Destruction of precancer skin growth, 1 growth | 283 | $19,681 | $48 |
| Biopsy of related skin growth, first growth | 149 | $14,823 | $83 |
| New patient visit (45+ min) | 69 | $9,309 | $135 |
| Destruction of precancer skin growth, 2-14 growths | 210 | $7,168 | $7 |
| New patient visit (30+ min) | 68 | $6,216 | $91 |
| Punch biopsy, first skin growth | 39 | $5,373 | $128 |
| Destruction of precancer skin growth, 15 or more growths | 20 | $4,030 | $168 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $3,891 | $299 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 14 | $2,560 | $151 |
| Biopsy of related skin growth, each additional growth | 26 | $1,895 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $76 | None |
2022: 15 services
| Return visit (30+ min) | 239 | $36,065 | $102 |
| Short return visit (20+ min) | 307 | $27,421 | $67 |
| Destruction of skin growth, 1-14 growths | 187 | $22,584 | $103 |
| Destruction of precancer skin growth, 1 growth | 328 | $19,359 | $45 |
| Biopsy of related skin growth, first growth | 155 | $14,528 | $83 |
| New patient visit (45+ min) | 63 | $8,820 | $140 |
| Destruction of precancer skin growth, 2-14 growths | 244 | $7,390 | $7 |
| New patient visit (30+ min) | 67 | $6,161 | $92 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 18 | $5,949 | $313 |
| Punch biopsy, first skin growth | 44 | $5,664 | $123 |
| Destruction of precancer skin growth, 15 or more growths | 27 | $4,190 | $150 |
| Biopsy of related skin growth, each additional growth | 35 | $3,247 | $53 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 15 | $2,111 | $124 |
| Short return visit | 13 | $615 | $47 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $49 | None |
2021: 19 services
| Short return visit (20+ min) | 413 | $49,260 | $75 |
| Return visit (30+ min) | 280 | $44,901 | $109 |
| Destruction of skin growth, 1-14 growths | 250 | $34,756 | $112 |
| Destruction of precancer skin growth, 1 growth | 417 | $28,147 | $46 |
| Biopsy of related skin growth, first growth | 199 | $21,454 | $91 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 44 | $14,938 | $311 |
| Destruction of precancer skin growth, 2-14 growths | 303 | $10,706 | $7 |
| Punch biopsy, first skin growth | 74 | $9,749 | $127 |
| Destruction of precancer skin growth, 15 or more growths | 38 | $7,443 | $165 |
| New patient visit (45+ min) | 55 | $7,075 | $129 |
| New patient visit (30+ min) | 76 | $6,723 | $88 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 23 | $5,104 | $165 |
| Biopsy of related skin growth, each additional growth | 53 | $4,069 | $55 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 25 | $3,729 | $133 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 17 | $2,455 | $144 |
| Short return visit | 42 | $2,214 | $48 |
| Punch biopsy, each additional skin growth | 12 | $763 | $64 |
| New patient visit (15+ min) | 11 | $711 | $65 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $67 | None |
2020: 19 services
| Short return visit (20+ min) | 495 | $44,342 | $61 |
| Destruction of skin growth, 1-14 growths | 233 | $29,731 | $109 |
| Destruction of precancer skin growth, 1 growth | 425 | $23,714 | $42 |
| Biopsy of related skin growth, first growth | 221 | $22,166 | $86 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 50 | $16,416 | $310 |
| Return visit (30+ min) | 151 | $14,462 | $90 |
| Destruction of precancer skin growth, 2-14 growths | 313 | $10,543 | $6 |
| Punch biopsy, first skin growth | 72 | $9,056 | $119 |
| New patient visit (30+ min) | 98 | $8,036 | $82 |
| Destruction of precancer skin growth, 15 or more growths | 46 | $7,388 | $154 |
| Biopsy of related skin growth, each additional growth | 60 | $5,289 | $55 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 34 | $4,703 | $127 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 23 | $3,785 | $151 |
| Short return visit | 64 | $3,070 | $41 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 20 | $2,863 | $143 |
| New patient visit (15+ min) | 17 | $1,200 | $71 |
| Punch biopsy, each additional skin growth | 13 | $806 | $58 |
| Injection into skin growth, 1-7 growths | 12 | $621 | $44 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $52 | None |
2019: 22 services
| Short return visit (20+ min) | 502 | $45,285 | $60 |
| Destruction of skin growth, 1-14 growths | 216 | $27,541 | $103 |
| Destruction of precancer skin growth, 1 growth | 403 | $23,656 | $43 |
| Biopsy of related skin growth, first growth | 187 | $18,665 | $84 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 42 | $12,529 | $298 |
| Return visit (30+ min) | 129 | $12,478 | $86 |
| New patient visit (30+ min) | 124 | $10,940 | $88 |
| Punch biopsy, first skin growth | 74 | $9,311 | $124 |
| Destruction of precancer skin growth, 2-14 growths | 308 | $8,627 | $5 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 13 | $6,023 | $430 |
| Destruction of precancer skin growth, 15 or more growths | 36 | $5,928 | $148 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 34 | $4,960 | $127 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 11 | $4,424 | $402 |
| Biopsy of related skin growth, each additional growth | 38 | $3,161 | $54 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 16 | $2,995 | $166 |
| Short return visit | 61 | $2,814 | $42 |
| Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 15 | $2,043 | $136 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 13 | $1,683 | $129 |
| Application of ultraviolet light to skin | 16 | $1,598 | $23 |
| New patient visit (15+ min) | 23 | $1,294 | $56 |
| Punch biopsy, each additional skin growth | 14 | $934 | $62 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $54 | None |
2018: 15 services
| Short return visit (20+ min) | 432 | $31,215 | $53 |
| Destruction of skin growth, 1-14 growths | 192 | $24,084 | $104 |
| Destruction of precancer skin growth, 1 growth | 341 | $17,018 | $41 |
| Biopsy of single growth of skin and/or tissue | 174 | $16,389 | $84 |
| Return visit (30+ min) | 98 | $9,392 | $84 |
| New patient visit (30+ min) | 101 | $7,936 | $79 |
| Destruction of precancer skin growth, 2-14 growths | 253 | $6,654 | $5 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 22 | $6,294 | $286 |
| Destruction of precancer skin growth, 15 or more growths | 22 | $3,352 | $129 |
| Short return visit | 50 | $2,183 | $39 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $1,950 | $122 |
| New patient visit (15+ min) | 32 | $1,704 | $53 |
| Biopsy of each additional growth of skin and/or tissue | 34 | $1,443 | $31 |
| Application of ultraviolet light to skin | 12 | $646 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $37 | None |
2017: 16 services
| Short return visit (20+ min) | 491 | $44,215 | $56 |
| Destruction of skin growth, 1-14 growths | 285 | $36,082 | $98 |
| Destruction of precancer skin growth, 1 growth | 393 | $24,587 | $43 |
| Biopsy of single growth of skin and/or tissue | 230 | $22,686 | $82 |
| Return visit (30+ min) | 127 | $13,145 | $85 |
| New patient visit (30+ min) | 137 | $11,318 | $83 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 35 | $11,224 | $288 |
| Destruction of precancer skin growth, 2-14 growths | 295 | $8,800 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 30 | $5,194 | $144 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 32 | $4,477 | $121 |
| Short return visit | 63 | $3,032 | $39 |
| Biopsy of each additional growth of skin and/or tissue | 39 | $1,535 | $31 |
| New patient visit (15+ min) | 24 | $1,259 | $52 |
| Application of ultraviolet light to skin | 12 | $953 | $22 |
| Injection into skin growth, 1-7 growths | 11 | $534 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $96 | None |
2016: 16 services
| Short return visit (20+ min) | 431 | $40,051 | $57 |
| Destruction of skin growth, 1-14 growths | 262 | $36,418 | $106 |
| Biopsy of single growth of skin and/or tissue | 246 | $22,762 | $78 |
| Destruction of precancer skin growth, 1 growth | 333 | $18,550 | $40 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 35 | $10,174 | $291 |
| Return visit (30+ min) | 85 | $8,823 | $83 |
| Destruction of precancer skin growth, 2-14 growths | 253 | $8,445 | $5 |
| New patient visit (30+ min) | 89 | $7,291 | $82 |
| Destruction of precancer skin growth, 15 or more growths | 29 | $4,474 | $140 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 30 | $3,841 | $120 |
| New patient visit (15+ min) | 50 | $2,884 | $58 |
| Short return visit | 66 | $2,715 | $39 |
| Biopsy of each additional growth of skin and/or tissue | 47 | $1,874 | $28 |
| Application of ultraviolet light to skin | 13 | $1,217 | $20 |
| Injection into skin growth, 1-7 growths | 11 | $806 | $47 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $32 | None |
2015: 15 services
| Short return visit (20+ min) | 403 | $37,637 | $62 |
| Destruction of skin growth, 1-14 growths | 216 | $29,378 | $111 |
| Biopsy of single growth of skin and/or tissue | 233 | $24,506 | $87 |
| Destruction of precancer skin growth, 1 growth | 305 | $17,837 | $44 |
| Return visit (30+ min) | 88 | $9,675 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 224 | $7,424 | $6 |
| New patient visit (30+ min) | 84 | $6,968 | $83 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 17 | $6,951 | $409 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 24 | $6,724 | $280 |
| Destruction of precancer skin growth, 15 or more growths | 28 | $5,057 | $144 |
| New patient visit (15+ min) | 84 | $4,991 | $59 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 28 | $3,883 | $125 |
| Short return visit | 42 | $2,071 | $43 |
| Biopsy of each additional growth of skin and/or tissue | 42 | $1,756 | $31 |
| Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,011 | $84 |
2014: 17 services
| Short return visit (20+ min) | 335 | $31,985 | $60 |
| Destruction of skin growth, 1-14 growths | 170 | $21,815 | $102 |
| Biopsy of single growth of skin and/or tissue | 226 | $21,815 | $83 |
| Destruction of precancer skin growth, 1 growth | 266 | $17,514 | $47 |
| Destruction of precancer skin growth, 2-14 growths | 183 | $11,090 | $10 |
| New patient visit (30+ min) | 116 | $9,412 | $81 |
| Return visit (30+ min) | 65 | $7,843 | $94 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 25 | $7,227 | $278 |
| Destruction of precancer skin growth, 15 or more growths | 32 | $5,735 | $140 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 17 | $5,646 | None |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 25 | $3,532 | $122 |
| Short return visit | 69 | $3,259 | $39 |
| Application of light to destroy precancer skin growth | 16 | $2,499 | $139 |
| Biopsy of each additional growth of skin and/or tissue | 54 | $2,437 | $30 |
| New patient visit (15+ min) | 44 | $2,379 | $54 |
| Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,024 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 18 | $831 | $35 |
2013: 14 services
| Short return visit (20+ min) | 255 | $23,207 | $59 |
| Destruction of skin growth, 1-14 growths | 144 | $19,225 | $108 |
| Biopsy of single growth of skin and/or tissue | 182 | $18,668 | $87 |
| Destruction of precancer skin growth, 1 growth | 210 | $15,969 | $54 |
| Return visit (30+ min) | 88 | $11,768 | $90 |
| New patient visit (30+ min) | 110 | $9,704 | $88 |
| Destruction of precancer skin growth, 15 or more growths | 34 | $7,402 | $154 |
| Destruction of precancer skin growth, 2-14 growths | 171 | $6,481 | $6 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $3,934 | $303 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $2,560 | $128 |
| Short return visit | 53 | $2,398 | $39 |
| New patient visit (15+ min) | 31 | $1,689 | $54 |
| Biopsy of each additional growth of skin and/or tissue | 41 | $1,686 | $30 |
| Pathology examination of tissue using a microscope, intermediate complexity | 15 | $647 | $22 |
Medicaid work
$4,120 in 2024
Medicaid paid $4,120 for 39 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 39 | $4,120 |
| 2024 | 39 | 1 | 14 | $4,120 |
| 2023 | 62 | 1 | 19 | $1,519 |
| 2022 | 13 | 1 | 13 | $66 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 62 | $1,519 |
2022
| Return visit (30+ min) | 13 | $66 |
Drugs they prescribed that Part D paid
$501,126
Pharmacies billed $501,126 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,421) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,275 generic and fewer than 11 brand-name prescriptions · $501,126 in drug cost · 116 antibiotic prescriptions to 64 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 31 | $211,551 | $6,824 |
| Dupixent | 19 | $72,172 | $3,799 |
| Clobetasol Propionate | 114 | $6,043 | $53 |
| Fluocinonide | 125 | $4,903 | $39 |
| Ketoconazole | 187 | $3,613 | $19 |
See all 25 drugs
| Humira(Cf) | 31 | $211,551 | $6,824 |
| Dupixent | 19 | $72,172 | $3,799 |
| Clobetasol Propionate | 114 | $6,043 | $53 |
| Fluocinonide | 125 | $4,903 | $39 |
| Ketoconazole | 187 | $3,613 | $19 |
| Tacrolimus | 23 | $3,054 | $133 |
| Metronidazole | 64 | $2,889 | $45 |
| Halobetasol Propionate | 30 | $2,683 | $89 |
| Mometasone Furoate | 131 | $2,278 | $17 |
| Betamethasone Dipropionate | 25 | $2,177 | $87 |
| Desonide | 42 | $2,141 | $51 |
| Doxycycline Hyclate | 90 | $2,109 | $23 |
| Fluorouracil | 30 | $1,985 | $66 |
| Betamethasone Valerate | 60 | $1,500 | $25 |
| Triamcinolone Acetonide | 50 | $752 | $15 |
| Fluticasone Propionate | 17 | $603 | $35 |
| Betamethasone Diprop Augmented | 14 | $544 | $39 |
| Hydrocortisone | 89 | $539 | $6 |
| Nystatin | 36 | $513 | $14 |
| Valacyclovir | 20 | $403 | $20 |
| Econazole Nitrate | 14 | $336 | $24 |
| Hydroxyzine | 16 | $327 | $20 |
| Mupirocin | 39 | $294 | $8 |
| Spironolactone | 12 | $204 | $17 |
| Cephalexin | 23 | $124 | $5 |
Year by year
| 2024 | 1,421 | 493 | 0% (0) | None | $501,126 |
| 2023 | 1,140 | 403 | 0% (0) | 10% | $356,673 |
| 2022 | 1,086 | 395 | 0% (0) | 7% | $192,818 |
| 2021 | 1,141 | 412 | 0% (0) | 9% | $175,127 |
| 2020 | 934 | 403 | 0% (0) | 9% | $67,490 |
| 2019 | 773 | 359 | 0% (0) | 9% | $37,599 |
| 2018 | 759 | 304 | 0% (0) | 9% | $61,053 |
| 2017 | 824 | 340 | 0% (0) | 11% | $49,123 |
| 2016 | 610 | 260 | None | 12% | $52,847 |
| 2015 | 591 | 252 | None | 13% | $60,857 |
| 2014 | 567 | 223 | 0% (0) | None | $35,740 |
| 2013 | 522 | 214 | None | 18% | $36,065 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Humira(Cf) | 26 | $188,716 | $7,258 |
| Dupixent | 17 | $62,792 | $3,694 |
| Fluocinonide | 119 | $6,316 | $53 |
| Clobetasol Propionate | 66 | $3,513 | $53 |
| Betamethasone Dipropionate | 41 | $3,484 | $85 |
| Tacrolimus | 24 | $3,388 | $141 |
| Ketoconazole | 137 | $2,978 | $22 |
| Betamethasone Diprop Augmented | 48 | $2,942 | $61 |
| Mometasone Furoate | 96 | $1,963 | $20 |
| Doxycycline Hyclate | 47 | $1,844 | $39 |
| Metronidazole | 26 | $1,596 | $61 |
| Desonide | 31 | $1,481 | $48 |
| Fluorouracil | 23 | $1,283 | $56 |
| Valacyclovir | 28 | $769 | $27 |
| Triamcinolone Acetonide | 39 | $504 | $13 |
| Hydrocortisone | 84 | $490 | $6 |
| Betamethasone Valerate | 15 | $487 | $32 |
| Nystatin | 34 | $403 | $12 |
| Mupirocin | 45 | $368 | $8 |
| Fluticasone Propionate | 11 | $361 | $33 |
| Cephalexin | 28 | $289 | $10 |
| Econazole Nitrate | 13 | $242 | $19 |
| Prednisone | 26 | $241 | $9 |
2022: 25 drugs
| Humira(Cf) | 11 | $74,971 | $6,816 |
| Dupixent | 14 | $47,627 | $3,402 |
| Fluocinonide | 134 | $7,532 | $56 |
| Clobetasol Propionate | 80 | $5,225 | $65 |
| Ivermectin | 11 | $5,049 | $459 |
| Ketoconazole | 176 | $4,652 | $26 |
| Tacrolimus | 20 | $3,730 | $187 |
| Betamethasone Diprop Augmented | 47 | $3,176 | $68 |
| Fluorouracil | 29 | $2,977 | $103 |
| Metronidazole | 29 | $2,400 | $83 |
| Betamethasone Dipropionate | 13 | $1,558 | $120 |
| Mometasone Furoate | 76 | $1,539 | $20 |
| Triamcinolone Acetonide | 53 | $708 | $13 |
| Desonide | 18 | $704 | $39 |
| Nystatin | 43 | $648 | $15 |
| Doxycycline Hyclate | 27 | $603 | $22 |
| Ciclopirox | 13 | $595 | $46 |
| Valacyclovir | 21 | $516 | $25 |
| Hydrocortisone | 76 | $461 | $6 |
| Fluticasone Propionate | 12 | $396 | $33 |
| Mupirocin | 40 | $394 | $10 |
| Spironolactone | 14 | $367 | $26 |
| Hydroxyzine | 11 | $263 | $24 |
| Prednisone | 13 | $211 | $16 |
| Terbinafine | 12 | $49 | $4 |
2021: 26 drugs
| Humira(Cf) | 11 | $70,245 | $6,386 |
| Dupixent | 14 | $45,409 | $3,244 |
| Calcipotriene | 17 | $8,543 | $503 |
| Fluocinonide | 129 | $6,545 | $51 |
| Ketoconazole | 156 | $5,338 | $34 |
| Fluorouracil | 47 | $3,811 | $81 |
| Metronidazole | 42 | $3,591 | $85 |
| Tacrolimus | 14 | $3,359 | $240 |
| Clobetasol Propionate | 59 | $3,094 | $52 |
| Betamethasone Dipropionate | 31 | $3,012 | $97 |
| Betamethasone Valerate | 13 | $2,724 | $210 |
| Betamethasone Diprop Augmented | 33 | $2,043 | $62 |
| Doxycycline Hyclate | 36 | $1,825 | $51 |
| Mometasone Furoate | 65 | $1,330 | $20 |
| Desonide | 17 | $1,079 | $63 |
| Ciclopirox | 22 | $1,016 | $46 |
| Fluticasone Propionate | 20 | $627 | $31 |
| Valacyclovir | 25 | $624 | $25 |
| Hydrocortisone | 74 | $590 | $8 |
| Triamcinolone Acetonide | 54 | $583 | $11 |
| Nystatin | 35 | $461 | $13 |
| Spironolactone | 16 | $443 | $28 |
| Mupirocin | 47 | $395 | $8 |
| Prednisone | 17 | $214 | $13 |
| Cephalexin | 34 | $196 | $6 |
| Hydroxyzine | 16 | $119 | $7 |
2020: 20 drugs
| Fluocinonide | 119 | $6,341 | $53 |
| Metronidazole | 58 | $5,272 | $91 |
| Fluorouracil | 42 | $4,591 | $109 |
| Ketoconazole | 109 | $4,149 | $38 |
| Clobetasol Propionate | 49 | $3,594 | $73 |
| Betamethasone Diprop Augmented | 32 | $2,057 | $64 |
| Clobetasol Emollient | 13 | $1,432 | $110 |
| Betamethasone Dipropionate | 14 | $1,233 | $88 |
| Spironolactone | 23 | $1,154 | $50 |
| Betamethasone Valerate | 26 | $1,148 | $44 |
| Doxycycline Hyclate | 29 | $1,006 | $35 |
| Ciclopirox | 20 | $993 | $50 |
| Mometasone Furoate | 44 | $778 | $18 |
| Nystatin | 37 | $675 | $18 |
| Clindamycin Phos-Benzoyl Perox | 11 | $489 | $44 |
| Mupirocin | 47 | $425 | $9 |
| Fluticasone Propionate | 16 | $424 | $27 |
| Hydrocortisone | 60 | $411 | $7 |
| Triamcinolone Acetonide | 44 | $307 | $7 |
| Cephalexin | 41 | $221 | $5 |
2019: 18 drugs
| Fluocinonide | 91 | $4,899 | $54 |
| Fluorouracil | 30 | $3,629 | $121 |
| Metronidazole | 32 | $3,264 | $102 |
| Clobetasol Propionate | 43 | $2,846 | $66 |
| Ketoconazole | 77 | $2,779 | $36 |
| Tretinoin | 14 | $2,102 | $150 |
| Betamethasone Diprop Augmented | 31 | $1,778 | $57 |
| Betamethasone Dipropionate | 18 | $1,457 | $81 |
| Clindamycin Phosphate | 33 | $1,440 | $44 |
| Doxycycline Hyclate | 21 | $1,369 | $65 |
| Mometasone Furoate | 27 | $705 | $26 |
| Spironolactone | 17 | $572 | $34 |
| Triamcinolone Acetonide | 79 | $491 | $6 |
| Cephalexin | 58 | $476 | $8 |
| Mupirocin | 48 | $473 | $10 |
| Ciclopirox | 11 | $341 | $31 |
| Hydrocortisone | 25 | $167 | $7 |
| Valacyclovir | 13 | $141 | $11 |
2018: 19 drugs
| Fluocinonide | 133 | $8,593 | $65 |
| Fluorouracil | 25 | $3,230 | $129 |
| Metronidazole | 31 | $2,847 | $92 |
| Clobetasol Propionate | 28 | $2,747 | $98 |
| Ketoconazole | 81 | $2,528 | $31 |
| Ciclopirox | 20 | $1,288 | $64 |
| Desonide | 12 | $1,278 | $106 |
| Clindamycin Phosphate | 18 | $1,215 | $68 |
| Spironolactone | 43 | $794 | $18 |
| Betamethasone Diprop Augmented | 15 | $673 | $45 |
| Triamcinolone Acetonide | 76 | $663 | $9 |
| Doxycycline Hyclate | 17 | $633 | $37 |
| Fluticasone Propionate | 21 | $529 | $25 |
| Mupirocin | 45 | $419 | $9 |
| Mometasone Furoate | 14 | $377 | $27 |
| Doxepin | 11 | $306 | $28 |
| Hydrocortisone | 28 | $255 | $9 |
| Cephalexin | 24 | $147 | $6 |
| Valacyclovir | 16 | $137 | $9 |
2017: 19 drugs
| Fluocinonide | 113 | $8,339 | $74 |
| Clobetasol Propionate | 51 | $6,366 | $125 |
| Fluorouracil | 41 | $4,630 | $113 |
| Ketoconazole | 88 | $4,108 | $47 |
| Metronidazole | 25 | $2,885 | $115 |
| Doxycycline Hyclate | 49 | $2,571 | $52 |
| Betamethasone Dipropionate | 21 | $1,663 | $79 |
| Methotrexate | 14 | $1,140 | $81 |
| Econazole Nitrate | 11 | $1,058 | $96 |
| Fluticasone Propionate | 32 | $936 | $29 |
| Triamcinolone Acetonide | 65 | $686 | $11 |
| Ciclopirox | 12 | $539 | $45 |
| Mupirocin | 54 | $491 | $9 |
| Hydroxyzine | 15 | $465 | $31 |
| Hydrocortisone | 39 | $343 | $9 |
| Mometasone Furoate | 14 | $330 | $24 |
| Cephalexin | 40 | $195 | $5 |
| Valacyclovir | 11 | $194 | $18 |
| Prednisone | 17 | $186 | $11 |
2016: 14 drugs
| Clobetasol Propionate | 59 | $12,631 | $214 |
| Fluocinonide | 108 | $7,861 | $73 |
| Econazole Nitrate | 24 | $4,708 | $196 |
| Desonide | 21 | $2,912 | $139 |
| Fluorouracil | 22 | $2,639 | $120 |
| Metronidazole | 22 | $2,510 | $114 |
| Doxycycline Hyclate | 36 | $1,935 | $54 |
| Ketoconazole | 51 | $911 | $18 |
| Clindamycin Phosphate | 14 | $869 | $62 |
| Triamcinolone Acetonide | 62 | $775 | $12 |
| Mupirocin | 30 | $350 | $12 |
| Hydrocortisone | 30 | $277 | $9 |
| Prednisone | 16 | $238 | $15 |
| Cephalexin | 29 | $144 | $5 |
2015: 12 drugs
| Clobetasol Propionate | 73 | $13,554 | $186 |
| Econazole Nitrate | 51 | $12,063 | $237 |
| Desonide | 52 | $5,958 | $115 |
| Fluocinonide | 61 | $5,001 | $82 |
| Fluorouracil | 23 | $2,839 | $123 |
| Doxycycline Hyclate | 27 | $2,136 | $79 |
| Metronidazole | 11 | $1,183 | $108 |
| Triamcinolone Acetonide | 49 | $501 | $10 |
| Mupirocin | 44 | $466 | $11 |
| Ketoconazole | 26 | $357 | $14 |
| Cephalexin | 37 | $298 | $8 |
| Sulfamethoxazole-Trimethoprim | 20 | $129 | $6 |
2014: 13 drugs
| Desonide | 51 | $6,401 | $126 |
| Doxycycline Hyclate | 40 | $4,230 | $106 |
| Fluocinonide | 67 | $4,030 | $60 |
| Fluorouracil | 21 | $3,380 | $161 |
| Clobetasol Propionate | 69 | $3,103 | $45 |
| Econazole Nitrate | 23 | $1,752 | $76 |
| Metronidazole | 15 | $1,594 | $106 |
| Triamcinolone Acetonide | 38 | $517 | $14 |
| Mupirocin | 47 | $515 | $11 |
| Ketoconazole | 26 | $357 | $14 |
| Minocycline | 16 | $276 | $17 |
| Cephalexin | 33 | $266 | $8 |
| Hydroxyzine | 12 | $180 | $15 |
2013: 13 drugs
| Desonide | 58 | $6,045 | $104 |
| Fluorouracil | 30 | $5,386 | $180 |
| Fluocinonide | 72 | $3,062 | $43 |
| Doxycycline Hyclate | 17 | $2,141 | $126 |
| Minocycline | 24 | $1,947 | $81 |
| Clobetasol Propionate | 53 | $1,801 | $34 |
| Metronidazole | 15 | $1,423 | $95 |
| Econazole Nitrate | 23 | $618 | $27 |
| Triamcinolone Acetonide | 35 | $493 | $14 |
| Ketoconazole | 30 | $479 | $16 |
| Mupirocin | 25 | $354 | $14 |
| Cephalexin | 33 | $226 | $7 |
| Sulfamethoxazole-Trimethoprim | 11 | $128 | $12 |
Money from drug and device companies
$171 in 2025
| 2025 | 5 | 8 | None | $171 |
| 2023 | 2 | 3 | None | $48 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | Zoryve | $59 | 3 payments
|
| Galderma Laboratories L.P. | Nemluvio | $53 | 2 payments
|
| Botanix SB | Sofdra | $25 | 1 payment
|
| Cipher Pharmaceuticals US | Natroba | $19 | 1 payment
|
| Janssen Biotech | Tremfya | $15 | 1 payment
|
See all 8 published payments
| Cipher Pharmaceuticals US | Meals · 2025-12-01 | Natroba | $19 |
| Arcutis Biotherapeutics | Meals · 2025-12-01 | Zoryve | $14 |
| Galderma Laboratories L.P. | Meals · 2025-11-12 | Nemluvio | $39 |
| Botanix SB | Meals · 2025-11-11 | Sofdra | $25 |
| Arcutis Biotherapeutics | Meals · 2025-10-22 | Zoryve | $25 |
| Janssen Biotech | Meals · 2025-10-13 | Tremfya | $15 |
| Arcutis Biotherapeutics | Meals · 2025-09-23 | Zoryve | $19 |
| Galderma Laboratories L.P. | Meals · 2025-09-02 | Nemluvio | $15 |
See earlier years (2023)
2023: $48
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $32 | 2 payments
|
| Pfizer | Cibinqo | $15 | 1 payment
|
Professional record
- NPI
- 1831380112
- Licence
- CA A98593California A98593: Current · expires 2028-03-31
- Trained
- Stanford University School of Medicine, 2004
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-08-05
- NPI last updated
- 2011-11-29
This is when the NPI record was last certified, not a medical board exam.